Active Ingredient History
Omeprazole, sold under the brand names Prilosec and Losec, among others, is a medication used in the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger–Ellison syndrome. It is also used to prevent upper gastrointestinal bleeding in people who are at high risk. Omeprazole is a proton-pump inhibitor (PPI) and its effectiveness is similar to that of other PPIs. It can be taken by mouth or by injection into a vein. It is also available in the fixed-dose combination medication omeprazole/sodium bicarbonate as Zegerid and as Konvomep. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Stomach Ulcer (approved 2008)
Zollinger-Ellison Syndrome (approved 2008)
Achlorhydria (Phase 4)
Acute Coronary Syndrome (Phase 4)
Airway Management (Phase 1)
Alzheimer Disease (Phase 1)
Analgesics, Opioid (Phase 4)
Anemia (Phase 1)
Anemia, Dyserythropoietic, Congenital (Phase 4)
Anemia, Iron-Deficiency (Phase 4)
Anemia, Sickle Cell (Phase 1)
Anesthesia (Phase 4)
Arthritis, Rheumatoid (Phase 4)
Autism Spectrum Disorder (Phase 1/Phase 2)
Autoimmune Diseases (Phase 1)
Back Pain (Phase 4)
Bariatric Surgery (Phase 4)
Barrett Esophagus (Phase 4)
Breast Neoplasms (Phase 2)
Breast Neoplasms, Male (Phase 1)
Carcinoma, Squamous Cell (Phase 2)
Central Serous Chorioretinopathy (Phase 1/Phase 2)
Chronic Pain (Phase 1)
Clostridioides difficile (Phase 4)
Clostridium Infections (Phase 1)
Colitis, Ulcerative (Phase 4)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 1)
Compliance (Phase 4)
Constipation (Phase 4)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Cough (Phase 3)
Crohn Disease (Phase 4)
Cystic Fibrosis (Phase 2)
Cytochrome P-450 CYP2C19 (Phase 4)
Depression (Phase 4)
Dermatitis, Atopic (Phase 1)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 1 (Phase 3)
Diabetes Mellitus, Type 2 (Phase 2)
Drug Interactions (Phase 4)
Dyspepsia (Phase 4)
Endoscopy (Phase 3)
Eosinophilic Esophagitis (Phase 4)
Erectile Dysfunction (Phase 1)
Esophageal Atresia (Phase 3)
Esophagitis (Phase 4)
Esophagitis, Peptic (Phase 3)
Eustachian Tube (Phase 4)
Exocrine Pancreatic Insufficiency (Phase 3)
Extrapyramidal Tracts (Phase 4)
Fatty Liver (Phase 2)
Fibrosis (Phase 1)
Food Hypersensitivity (Phase 4)
Gastric Acid (Phase 3)
Gastrinoma (Phase 2)
Gastritis (Phase 3)
Gastrointestinal Hemorrhage (Phase 3)
Gastroparesis (Phase 4)
General Surgery (Phase 4)
Glaucoma (Phase 1)
Globus Sensation (Phase 3)
Gout (Phase 4)
Graft Rejection (Phase 4)
Granuloma (Phase 2)
Granuloma, Laryngeal (Phase 2)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 4)
Heartburn (Phase 4)
Helicobacter Infections (Phase 4)
Helicobacter pylori (Phase 4)
Hemorrhage (Phase 4)
Hepatitis B, Chronic (Phase 1)
Hepatitis C (Phase 1)
Hepatitis C, Chronic (Phase 1)
Hernia, Diaphragmatic (Phase 3)
Hip Fractures (Phase 4)
HIV Infections (Phase 1)
Human Experimentation (Phase 3)
Huntington Disease (Phase 1)
Hypoalbuminemia (Phase 4)
Idiopathic Pulmonary Fibrosis (Phase 2)
Infections ()
Inflammation (Phase 4)
Inflammatory Bowel Diseases (Phase 4)
Insulin Resistance (Phase 2)
Intestinal Neoplasms (Phase 4)
Laryngomalacia (Phase 1)
Laryngopharyngeal Reflux (Phase 4)
Leukemia, Myeloid, Acute (Phase 1)
Liver Diseases (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Lymphoma, Mantle-Cell (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Melanoma (Phase 1)
Metabolic Detoxication, Phase I (Phase 1)
Metabolism (Phase 1)
Mitochondrial Diseases (Phase 1)
Motor Activity (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 3)
Muscular Atrophy, Spinal (Phase 1)
Myocardial Infarction (Phase 3)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 2)
Neurocysticercosis (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 2)
Obesity, Morbid (Phase 1/Phase 2)
Osteoarthritis (Phase 4)
Osteoporosis (Phase 4)
Overweight (Phase 1/Phase 2)
Pain (Phase 4)
Pancreatectomy (Phase 3)
Pancreatic Neoplasms (Early Phase 1)
Pancreatitis, Chronic (Phase 3)
Parkinson Disease (Phase 3)
Peptic Ulcer ()
Peptic Ulcer Hemorrhage (Phase 4)
Percutaneous Coronary Intervention (Phase 3)
Pharmacokinetics (Phase 1)
Pharmacologic Actions (Phase 1)
Platelet Aggregation (Phase 1)
Porphyria, Acute Intermittent (Phase 1)
Porphyrias (Phase 1)
Pregnancy Complications (Phase 4)
Probiotics (Phase 4)
Prostatic Neoplasms (Phase 2)
Proton Pump Inhibitors (Phase 1)
Psoriasis (Phase 1)
Pulmonary Disease, Chronic Obstructive (Phase 1)
Respiratory Aspiration (Phase 4)
Rotator Cuff Injuries (Phase 4)
Safety (Phase 1)
Scleroderma, Systemic (Phase 1)
Sinusitis (Phase 4)
Sleep Apnea, Obstructive (Phase 1)
Spondylitis, Ankylosing (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Diseases (Phase 3)
Stomach Neoplasms (Phase 3)
Stomach Ulcer (Phase 4)
Therapeutics (Phase 4)
Thyroid Neoplasms (Phase 1)
Tinea cruris (Phase 4)
Tinea Pedis (Phase 4)
Triple Negative Breast Neoplasms (Phase 1)
Ulcer (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Volunteers (Phase 1)
Vulvar Neoplasms (Phase 2)
Zollinger-Ellison Syndrome (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
